Mark Lacy

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs.

Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA.

Clinical Research Holdings LLC provides commercial physical and biological research services. The firm specializes in Phase I/IIa Clinical Pharmacology, Outpatient Studies, In-Hospital Trials, Vaccines, Complex Clinical Trials, Special populations, Phase II, Phase III and Phase IV. The company was founded in 1998 and is headquartered in DeLand, FL.

Accel Clinical Services LLC provides clinical research services. It offers clinical trials in a wide range of therapeutic indications to pharmaceuticals, biotech start-ups, and contract research organizations. It conducts Phase I, In-Hospital, vaccine and outpatient Phase II-IV trials. The company was founded in 1998 and is headquartered in DeLand, FL.

Avanza Laboratories LLC provides pharmaceutical and agrochemical support. The company is headquartered in Gaithersburg, MD.

AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL.

Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a clinical research network that operates to develop new therapies. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022.